ICH, International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q10: Pharmaceutical Quality System Geneva, 2008.
ICH, International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q8(R2): Pharmaceutical Development, Geneva, 2009.
U.S.F.a.D.A. (FDA), Guidance for Industry PAT-A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance, FDA, 2004.
J. Luypaert, D.L. Massart, and Y. Vander Heyden Near-infrared spectroscopy applications in pharmaceutical analysis Talanta 72 2007 865 883
Y. Roggo, P. Chalus, L. Maurer, C. Lema-Martinez, A. Edmond, and N. Jent A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies J. Pharm. Biomed. Anal. 44 2007 683 700
D.A. Burns, and E.W. Ciurczak Handbook of Near-Infrared Analysis third ed. 2008 CRC Press New York
C. Bodson, E. Rozet, E. Ziemons, B. Evrard, P. Hubert, and L. Delattre Validation of manufacturing process of Diltiazem HCl tablets by NIR spectrophotometry (NIRS) J. Pharm. Biomed. Anal. 45 2007 356 361
J.J. Moes, M.M. Ruijken, E. Gout, H.W. Frijlink, and M.I. Ugwoke Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements Int. J. Pharm. 357 2008 108 118
H. Grohganz, D. Gildemyn, E. Skibsted, J.M. Flink, and J. Rantanen Towards a robust water content determination of freeze-dried samples by near-infrared spectroscopy Anal. Chim. Acta 676 2010 34 40
J. Mantanus, E. Ziémons, E. Rozet, B. Streel, R. Klinkenberg, B. Evrard, J. Rantanen, and P. Hubert Building the quality into pellet manufacturing environment - feasibility study and validation of an in-line quantitative near infrared (NIR) method Talanta 83 2010 305 311
M. Blanco, M. Alcalá, and M. Bautista Pharmaceutical gel analysis by NIR spectroscopy: determination of the active principle and low concentration of preservatives Eur. J. Pharm. Sci. 33 2008 409 414
J. Mantanus, E. Rozet, K. Van Butsele, C. De Bleye, A. Ceccato, B. Evrard, P. Hubert, and E. Ziémons Near infrared and Raman spectroscopy as Process Analytical Technology tools for the manufacturing of silicone-based drug reservoirs Anal. Chim. Acta 699 2011 96 106
F. Krier, J. Mantanus, P.-Y. Sacré, P.-F. Chavez, J. Thiry, A. Pestieau, E. Rozet, E. Ziemons, P. Hubert, and B. Evrard PAT tools for the control of co-extrusion implants manufacturing process Int. J. Pharm. 458 2013 15 24
P.-F. Chavez, P. Lebrun, P.-Y. Sacré, C. De Bleye, L. Netchacovitch, S. Cuypers, J. Mantanus, H. Motte, M. Schubert, B. Evrard, P. Hubert, and E. Ziemons Optimization of a pharmaceutical tablet formulation based on a design space approach and using vibrational spectroscopy as PAT tool Int. J. Pharm. 486 2015 13 20
M.-J. Lee, D.-Y. Seo, H.-E. Lee, I.-C. Wang, W.-S. Kim, M.-Y. Jeong, and G.J. Choi In line NIR quantification of film thickness on pharmaceutical pellets during a fluid bed coating process Int. J. Pharm. 403 2011 66 72
C.V. Möltgen, T. Puchert, J.C. Menezes, D. Lochmann, and G. Reich A novel in-line NIR spectroscopy application for the monitoring of tablet film coating in an industrial scale process Talanta 92 2012 26 37
A. Pestieau, F. Krier, G. Thoorens, A. Dupont, P.-F. Chavez, E. Ziemons, P. Hubert, and B. Evrard Towards a real time release approach for manufacturing tablets using NIR spectroscopy J. Pharm. Biomed. Anal. 98 2014 60 67
L. Saerens, L. Dierickx, T. Quinten, P. Adriaensens, R. Carleer, C. Vervaet, J.P. Remon, and T. De Beer In-line NIR spectroscopy for the understanding of polymer-drug interaction during pharmaceutical hot-melt extrusion Eur. J. Pharm. Biopharm. 81 2012 230 237
P.R. Wahl, G. Fruhmann, S. Sacher, G. Straka, S. Sowinski, and J.G. Khinast PAT for tableting: Inline monitoring of API and excipients via NIR spectroscopy Eur. J. Pharm. Biopharm. 87 2014 271 278
ICH, International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q2(R1): Validation of Analytical Procedures: Text and Methodology, Geneva, 2005.
P. Hubert, J.J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P.A. Compagnon, W. Dewé, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, and L. Valat Harmonization of strategies for the validation of quantitative analytical procedures: A SFSTP proposal - Part I J. Pharm. Biomed. Anal. 36 2004 579 586
P. Hubert, J.J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P.A. Compagnon, W. Dewé, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, L. Valat, and E. Rozet Harmonization of strategies for the validation of quantitative analytical procedures: A SFSTP proposal - Part II J. Pharm. Biomed. Anal. 45 2007 70 81
A. Bouabidi, E. Rozet, M. Fillet, E. Ziemons, E. Chapuzet, B. Mertens, R. Klinkenberg, A. Ceccato, M. Talbi, B. Streel, A. Bouklouze, B. Boulanger, and P. Hubert Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept J. Chromatogr. A 1217 2010 3180 3192
C. De Bleye, P.F. Chavez, J. Mantanus, R. Marini, P. Hubert, E. Rozet, and E. Ziemons Critical review of near-infrared spectroscopic methods validations in pharmaceutical applications J. Pharm. Biomed. Anal. 69 2012 125 132
A. Savitzky, and M.J.E. Golay Smoothing and differentiation of data by simplified least squares procedures Anal. Chem. 36 1964 1627 1639
A.M. Committee Uncertainty of measurement: implication of its use in the analytical science Analyst 120 1995 2303 2308
E.C. Guide, Quantifying the Uncertainty in Analytical Measurement, 2000.
R.D. Marini, P. Chiap, B. Boulanger, S. Rudaz, E. Rozet, J. Crommen, and P. Hubert LC method for the determination of R-timolol in S-timolol maleate: validation of its ability to quantify and uncertainty assessment Talanta 68 2006 1166 1175
C. EA-4/16, EA guidelines on the expression of uncertainty in quantitative testing, 2004.
J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 327 1986 307 310
